Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating activities
Net income (loss)	$ (71,279)	$ (13,473)	$ 31,667
Adjustments to reconcile net (loss) income to net cash flows from operating activities:
Depreciation, amortization and accretion	42,288	24,689	13,379
Impairment of long-lived assets	9,729	9,935	0
ARO acceleration	5,259	0	0
Amortization of debt related costs	676	119	978
Changes in fair value of contingent assets and liabilities	72,400	(2,000)	0
(Gain) loss on extinguishment of debt	(889)	0	3,196
Provision for excess and obsolete inventory	4,057	2,365	1,851
Stock-based compensation	15,934	14,075	12,492
(Gain) loss on disposal of assets	(15,263)	2,250	286
Deferred taxes	4,437	(1,334)	9,725
Long-term indemnification receivable	7,121	(2,218)	10,635
Long-term income tax payable and other long-term liabilities	(7,912)	2,828	(13,156)
Other	2,512	1,525	282
Increases (decreases) in cash from operating assets and liabilities:
Accounts receivable	(33,102)	(7,462)	156
Inventory	(3,549)	(8,459)	1,994
Other current assets	(73)	1,941	(2,411)
Accounts payable	5,425	(4,224)	3,233
Accrued expenses and other liabilities	16,145	(4,161)	6,077
Net cash provided by operating activities	53,916	16,396	80,384
Investing activities
Capital expenditures	(12,140)	(12,474)	(22,061)
Proceeds from sale of assets, net	15,823	0	0
Lending on bridge loan	0	(10,000)	0
Cash acquired in acquisition of business	0	17,562	0
Net cash provided by (used in) investing activities	3,683	(4,912)	(22,061)
Financing activities
Proceeds from issuance of common stock	767	683	573
Equity issuance costs	0	(3,777)	0
Proceeds from issuance of long-term debt	0	0	199,461
Payments on long-term debt and other borrowings	(43,348)	(15,491)	(275,376)
Deferred financing costs	0	(1,224)	(2,258)
Proceeds from stock option exercises	5,295	77	1,173
Payments for minimum statutory tax withholding related to net share settlement of equity awards	(2,046)	(2,129)	(2,454)
Net cash used in financing activities	(39,332)	(21,861)	(78,881)
Effect of foreign exchange rates on cash and cash equivalents	(310)	152	76
Net increase (decrease) in cash and cash equivalents and restricted cash	17,957	(10,225)	(20,482)
Cash and cash equivalents and restricted cash, beginning of year	82,694	92,919	113,401
Cash and cash equivalents and restricted cash, end of year	100,651	82,694	92,919
Reconciliation to amounts within the consolidated balance sheets
Cash and cash equivalents	98,508	79,612	92,919
Cash and cash equivalents included in assets held for sale	0	941	0
Restricted cash included in other long-term assets	2,143	2,141	0
Cash, cash equivalents and restricted cash at end of period	100,651	82,694	92,919
Supplemental disclosure of cash flow information
Interest	6,284	9,368	12,253
Income taxes, net of refunds of $315, $331 and $2, respectively	215	340	274
Schedule of non-cash investing and financing activities
Additions of property, plant and equipment included in liabilities	1,262	2,227	4,175
Consideration transferred in acquisition	$ 0	$ 419,009	$ 0